Preoperative iLux on Cataract Surgery Derived Dry Eye Disease Due to Meibomian Gland Dysfunction

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 3, 2024

Primary Completion Date

September 1, 2024

Study Completion Date

December 1, 2024

Conditions
Dry Eye DiseaseMeibomian Gland DysfunctionCataract SenileDry Eye Syndromes
Interventions
DEVICE

Systane iLux Treatment

The Systane iLux is an approved thermal pulsation device to treat dry eye disease. The application of heat and compression to both eyelids melts meibum in the obstructed glands to restore the secretion and production of meibum to the eye. The Systane iLux will only be administered to the eye to undergo cataract surgery.

Trial Locations (1)

20037

RECRUITING

George Washington University, Washington D.C.

All Listed Sponsors
lead

George Washington University

OTHER